Temozolomide in children with recurrent or refractory CNS tumors.
Recruiting
- Conditions
- recurrent primitive neuro ectodermal tumors and recurrent high grade gliomas of the CNS in children.
- Registration Number
- NL-OMON28755
- Lead Sponsor
- SKION (Stichting Kinder Oncologie); Schering Plough
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 54
Inclusion Criteria
1. Age 3-18;
2. Pathology: PNET/high grade glioma
measurable tumor;
Exclusion Criteria
Non conformation to inclusion criteria.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference in MRI respons after 12 weeks between the 2 arms.
- Secondary Outcome Measures
Name Time Method Difference in side effects after 12 weeks between the 2 arms.